Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.49.3.959-962.2005
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2005
Authors
Publisher
American Society for Microbiology